Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy.

Saved in:
Bibliographic Details
Title: Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy.
Authors: Feliz-Mosquea YR; Department of Surgery, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA., Christensen AA; Department of Surgery, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA., Wilson AS; Department of Surgery, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA., Westwood B; Department of Surgery, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA., Varagic J; Department of Surgery, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA.; Cardiovascular Sciences Center, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA., Meléndez GC; Internal Medicine, Section on Cardiovascular Medicine, Pathology Section on Comparative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA.; Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA.; Cardiovascular Sciences Center, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA., Schwartz AL; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Chen QR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Mathews Griner L; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, 20892, USA., Guha R; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, 20892, USA., Thomas CJ; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, 20892, USA., Ferrer M; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, 20892, USA., Merino MJ; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Cook KL; Department of Surgery, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA.; Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA.; Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA.; Cardiovascular Sciences Center, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA., Roberts DD; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Soto-Pantoja DR; Department of Surgery, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA. dsotopan@wakehealth.edu.; Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA. dsotopan@wakehealth.edu.; Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA. dsotopan@wakehealth.edu.; Cardiovascular Sciences Center, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA. dsotopan@wakehealth.edu.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Nov; Vol. 172 (1), pp. 69-82. Date of Electronic Publication: 2018 Jul 28.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-7217
DOI:10.1007/s10549-018-4884-x